GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Finds Language in Health Policies Influences Stigma and Access to Care for Perinatal Substance Use

by GOAI
Share To

Recent research highlights the significant impact of language used in health policies addressing perinatal substance use and mental health. A study conducted by Shahram, Knox, Black, and their team examines how naming conventions within policy frameworks influence perceptions, outcomes, and equity in managing substance use during pregnancy. The findings suggest that the terminology employed in these policies plays a critical role in shaping societal attitudes and the experiences of individuals navigating these systems.

The researchers analyzed the implications of specific language choices on stigma, access to care, and overall effectiveness of policies targeting perinatal substance use. Their work underscores how certain terms may inadvertently reinforce negative stereotypes or create barriers to support for affected individuals. By exploring this intersection between language and policy design, the study aims to inform future approaches that prioritize inclusivity and equity while addressing complex health challenges.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top